Eisenberg M, et al A call to establish a global resuscitation alliance. 2018 [ONLINE] Available at: https://foundation915.files.wordpress.com/2016/07/a-call-to-establish-a-global-resuscitation-alliance-2016.pdf [Accessed November 18 2019].
Eisenberg M, et al Acting on the Call. 2019 [ONLINE] Available at: http://www.globalresuscitationalliance.org/wp-content/pdf/acting_on_the_call.pdf
Lattimore S, Wickenden C, Brailsford SR Blood donors in England and North Wales: demography and patterns of donation. Transfusion. 2015 Jan;55(1):91-9. doi: 10.1111/trf.12835. Epub 2014 Sep 1.
Ou Y, Yau KK, Poon CM, Hui YV, Lee SS, Lee CK Donation frequency and its association with demographic characteristics--a 1-year observational study. Transfus Med. 2015 Dec;25(6):366-73. doi: 10.1111/tme.12267. Epub 2016 Jan 5.
TrygFonden [Internet/in Danish] [cited 2019 Nov 06]; Available from: https://genoplivning.dk/nyt-studie-4-5-danskere-har-vaeret-paa-foerstehjaelpskursus/
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.